But there is Value in the cupboard that could benefit PAA the company ,,, plus it was the basis for Human Cancer ,,,, so there is Value in proven Tech,, if the Current Management do not wish to pursue K9 Cancer then we need to realise the SH value already invested circa $39m was raised for K9 Cancer .
Fully agree with not pursuing K9 Cancer but you don't just leave $39m in technology behind and not try and realise some value back into the company .... certainly prevent further dilution NZT
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-435
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.010(5.26%) |
Mkt cap ! $98.34M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 19.5¢ | $86.20K | 429.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 67508 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 36444 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |